Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 75

1.

Postponed or immediate drainage of infected necrotizing pancreatitis (POINTER trial): study protocol for a randomized controlled trial.

van Grinsven J, van Dijk SM, Dijkgraaf MG, Boermeester MA, Bollen TL, Bruno MJ, van Brunschot S, Dejong CH, van Eijck CH, van Lienden KP, Boerma D, van Duijvendijk P, Hadithi M, Haveman JW, van der Hulst RW, Jansen JM, Lips DJ, Manusama ER, Molenaar IQ, van der Peet DL, Poen AC, Quispel R, Schaapherder AF, Schoon EJ, Schwartz MP, Seerden TC, Spanier BWM, Straathof JW, Venneman NG, van de Vrie W, Witteman BJ, van Goor H, Fockens P, van Santvoort HC, Besselink MG; Dutch Pancreatitis Study Group.

Trials. 2019 Apr 25;20(1):239. doi: 10.1186/s13063-019-3315-6.

2.

Yield of Surveillance Colonoscopies 1 Year After Curative Surgical Colorectal Cancer Resections.

van Lanschot MCJ, van Leerdam ME, Lansdorp-Vogelaar I, Doets S, Nagtegaal ID, Schreurs HW, van der Hulst RWM, Carvalho B, Dekker E, van Berkel AM.

Clin Gastroenterol Hepatol. 2019 Oct;17(11):2285-2293. doi: 10.1016/j.cgh.2019.02.026. Epub 2019 Feb 22.

PMID:
30802606
3.

Fluid hydration to prevent post-ERCP pancreatitis in average- to high-risk patients receiving prophylactic rectal NSAIDs (FLUYT trial): study protocol for a randomized controlled trial.

Smeets XJNM, da Costa DW, Fockens P, Mulder CJJ, Timmer R, Kievit W, Zegers M, Bruno MJ, Besselink MGH, Vleggaar FP, van der Hulst RWM, Poen AC, Heine GDN, Venneman NG, Kolkman JJ, Baak LC, Römkens TEH, van Dijk SM, Hallensleben NDL, van de Vrie W, Seerden TCJ, Tan ACITL, Voorburg AMCJ, Poley JW, Witteman BJ, Bhalla A, Hadithi M, Thijs WJ, Schwartz MP, Vrolijk JM, Verdonk RC, van Delft F, Keulemans Y, van Goor H, Drenth JPH, van Geenen EJM; Dutch Pancreatitis Study Group.

Trials. 2018 Apr 2;19(1):207. doi: 10.1186/s13063-018-2583-x.

4.

The difference in endoscopic yield in patients with either iron-deficiency anemia or anemia with normal ferritin.

Kwakman JA, van Oostveen CJ, van Stralen KJ, Cleeren E, Neerincx M, van der Hulst RWM.

Eur J Gastroenterol Hepatol. 2018 Apr;30(4):424-431. doi: 10.1097/MEG.0000000000001039.

PMID:
29240003
5.

Novel Stool-Based Protein Biomarkers for Improved Colorectal Cancer Screening: A Case-Control Study.

Bosch LJW, de Wit M, Pham TV, Coupé VMH, Hiemstra AC, Piersma SR, Oudgenoeg G, Scheffer GL, Mongera S, Sive Droste JT, Oort FA, van Turenhout ST, Larbi IB, Louwagie J, van Criekinge W, van der Hulst RWM, Mulder CJJ, Carvalho B, Fijneman RJA, Jimenez CR, Meijer GA.

Ann Intern Med. 2017 Dec 19;167(12):855-866. doi: 10.7326/M17-1068. Epub 2017 Nov 21.

PMID:
29159365
6.

Systematic review: periprocedural hydration in the prevention of post-ERCP pancreatitis.

Smeets XJ, da Costa DW, Besselink MG, Bruno MJ, Fockens P, Mulder CJ, van der Hulst RW, Vleggaar FP, Timmer R, Drenth JP, van Geenen EJ.

Aliment Pharmacol Ther. 2016 Sep;44(6):541-53. doi: 10.1111/apt.13744. Epub 2016 Jul 22. Review.

7.

Factors associated with anxiety and depressive symptoms in colorectal cancer survivors.

Braamse AM, van Turenhout ST, Terhaar Sive Droste JS, de Groot GH, van der Hulst RW, Klemt-Kropp M, Kuiken SD, Loffeld RJ, Uiterwaal MT, Mulder CJ, Dekker J.

Eur J Gastroenterol Hepatol. 2016 Jul;28(7):831-5. doi: 10.1097/MEG.0000000000000615.

PMID:
26928565
8.

Early biliary decompression versus conservative treatment in acute biliary pancreatitis (APEC trial): study protocol for a randomized controlled trial.

Schepers NJ, Bakker OJ, Besselink MG, Bollen TL, Dijkgraaf MG, van Eijck CH, Fockens P, van Geenen EJ, van Grinsven J, Hallensleben ND, Hansen BE, van Santvoort HC, Timmer R, Anten MP, Bolwerk CJ, van Delft F, van Dullemen HM, Erkelens GW, van Hooft JE, Laheij R, van der Hulst RW, Jansen JM, Kubben FJ, Kuiken SD, Perk LE, de Ridder RJ, Rijk MC, Römkens TE, Schoon EJ, Schwartz MP, Spanier BW, Tan AC, Thijs WJ, Venneman NG, Vleggaar FP, van de Vrie W, Witteman BJ, Gooszen HG, Bruno MJ; Dutch Pancreatitis Study Group.

Trials. 2016 Jan 5;17:5. doi: 10.1186/s13063-015-1132-0.

9.

Prospective cross-sectional study on faecal immunochemical tests: sex specific cut-off values to obtain equal sensitivity for colorectal cancer?

van Turenhout ST, Oort FA, van der Hulst RW, Visscher AP, Terhaar sive Droste JS, Scholten P, Bouman AA, Meijer GA, Mulder CJ, van Rossum LG, Coupé VM.

BMC Gastroenterol. 2014 Dec 21;14:217. doi: 10.1186/s12876-014-0217-7.

10.

Similar fecal immunochemical test results in screening and referral colorectal cancer.

van Turenhout ST, van Rossum LG, Oort FA, Laheij RJ, van Rijn AF, Terhaar sive Droste JS, Fockens P, van der Hulst RW, Bouman AA, Jansen JB, Meijer GA, Dekker E, Mulder CJ.

World J Gastroenterol. 2012 Oct 14;18(38):5397-403. doi: 10.3748/wjg.v18.i38.5397.

11.

Faecal immunochemical test accuracy in patients referred for surveillance colonoscopy: a multi-centre cohort study.

Terhaar sive Droste JS, van Turenhout ST, Oort FA, van der Hulst RW, Steeman VA, Coblijn U, van der Eem L, Duijkers R, Bouman AA, Meijer GA, Depla AC, Scholten P, Loffeld RJ, Coupé VM, Mulder CJ.

BMC Gastroenterol. 2012 Jul 24;12:94. doi: 10.1186/1471-230X-12-94.

12.

Hemorrhoids detected at colonoscopy: an infrequent cause of false-positive fecal immunochemical test results.

van Turenhout ST, Oort FA, Terhaar sive Droste JS, Coupé VM, van der Hulst RW, Loffeld RJ, Scholten P, Depla AC, Bouman AA, Meijer GA, Mulder CJ, van Rossum LG.

Gastrointest Endosc. 2012 Jul;76(1):136-43. doi: 10.1016/j.gie.2012.03.169.

PMID:
22726472
13.

Double sampling of a faecal immunochemical test is not superior to single sampling for detection of colorectal neoplasia: a colonoscopy controlled prospective cohort study.

Oort FA, van Turenhout ST, Coupé VM, van der Hulst RW, Wesdorp EI, Terhaar sive Droste JS, Larbi IB, Kanis SL, van Hengel E, Bouman AA, Meijer GA, Mulder CJ.

BMC Cancer. 2011 Oct 10;11:434. doi: 10.1186/1471-2407-11-434.

14.

Acute pancreatitis and concomitant use of pancreatitis-associated drugs.

Spanier BW, Tuynman HA, van der Hulst RW, Dijkgraaf MG, Bruno MJ.

Am J Gastroenterol. 2011 Dec;106(12):2183-8. doi: 10.1038/ajg.2011.303. Epub 2011 Sep 13.

PMID:
21912439
15.

Higher fecal immunochemical test cutoff levels: lower positivity rates but still acceptable detection rates for early-stage colorectal cancers.

Terhaar sive Droste JS, Oort FA, van der Hulst RW, van Heukelem HA, Loffeld RJ, van Turenhout ST, Ben Larbi I, Kanis SL, Neerincx M, Räkers M, Coupé VM, Bouman AA, Meijer GA, Mulder CJ.

Cancer Epidemiol Biomarkers Prev. 2011 Feb;20(2):272-80. doi: 10.1158/1055-9965.EPI-10-0848. Epub 2010 Dec 6.

16.

Colonic work-up after incomplete colonoscopy: significant new findings during follow-up.

Neerincx M, Terhaar sive Droste JS, Mulder CJ, Räkers M, Bartelsman JF, Loffeld RJ, Tuynman HA, Brohet RM, van der Hulst RW.

Endoscopy. 2010 Sep;42(9):730-5. doi: 10.1055/s-0030-1255523. Epub 2010 Jul 28.

PMID:
20669092
17.

Does delay in diagnosing colorectal cancer in symptomatic patients affect tumor stage and survival? A population-based observational study.

Terhaar sive Droste JS, Oort FA, van der Hulst RW, Coupé VM, Craanen ME, Meijer GA, Morsink LM, Visser O, van Wanrooij RL, Mulder CJ.

BMC Cancer. 2010 Jun 28;10:332. doi: 10.1186/1471-2407-10-332.

18.

Practice and yield of early CT scan in acute pancreatitis: a Dutch Observational Multicenter Study.

Spanier BW, Nio Y, van der Hulst RW, Tuynman HA, Dijkgraaf MG, Bruno MJ.

Pancreatology. 2010;10(2-3):222-8. doi: 10.1159/000243731. Epub 2010 May 17.

PMID:
20484959
19.

[Diagnosis of colorectal tumours in daily clinical practice: comparison of colonoscopy and sigmoidoscopy].

Terhaar sive Droste JS, van Wanrooij RL, Morsink LM, van der Hulst RW, Craanen ME, Bartelsman JW, Meijer GA, Mulder CJ.

Ned Tijdschr Geneeskd. 2009;153:A731. Dutch.

PMID:
20003556
20.

Colonoscopy-controlled intra-individual comparisons to screen relevant neoplasia: faecal immunochemical test vs. guaiac-based faecal occult blood test.

Oort FA, Terhaar Sive Droste JS, Van Der Hulst RW, Van Heukelem HA, Loffeld RJ, Wesdorp IC, Van Wanrooij RL, De Baaij L, Mutsaers ER, van der Reijt S, Coupe VM, Berkhof J, Bouman AA, Meijer GA, Mulder CJ.

Aliment Pharmacol Ther. 2010 Feb 1;31(3):432-9. doi: 10.1111/j.1365-2036.2009.04184.x. Epub 2009 Oct 29.

21.

Colonoscopic yield of colorectal neoplasia in daily clinical practice.

Terhaar Sive Droste JS, Craanen ME, van der Hulst RW, Bartelsman JF, Bezemer DP, Cappendijk KR, Meijer GA, Morsink LM, Snel P, Tuynman HA, van Wanrooy RL, Wesdorp EI, Mulder CJ.

World J Gastroenterol. 2009 Mar 7;15(9):1085-92.

22.

Spontaneous drainage of a pancreatic pseudocyst after embolization of a bleeding pseudoaneurysm.

Uiterwaal MT, Overbosch EH, Bruno MJ, van der Hulst RW.

Cardiovasc Intervent Radiol. 2009 Jan;32(1):192-4. doi: 10.1007/s00270-008-9404-7. Epub 2008 Sep 17. No abstract available.

23.

Nutritional management of patients with acute pancreatitis: a Dutch observational multicentre study.

Spanier BW, Mathus-Vliegen EM, Tuynman HA, Van der Hulst RW, Dijkgraaf MG, Bruno MJ; EARL Study Group.

Aliment Pharmacol Ther. 2008 Nov 1;28(9):1159-65. doi: 10.1111/j.1365-2036.2008.03814.x. Epub 2008 Jul 24.

24.

Paradoxical elevated thiopurine S-methyltransferase activity after pancytopenia during azathioprine therapy: potential influence of red blood cell age.

de Boer NK, van Bodegraven AA, de Graaf P, van der Hulst RW, Zoetekouw L, van Kuilenburg AB.

Ther Drug Monit. 2008 Jun;30(3):390-3. doi: 10.1097/FTD.0b013e31816c20b3.

PMID:
18520612
25.

[The effect of Helicobacter pylori eradication on chronic use of acid-suppressant medication by patients in general practice; a randomised, double-blind study].

Hurenkamp GJ, Grundmeijer HG, van der Ende A, Tytgat GN, Assendelft WJ, van der Hulst RW.

Ned Tijdschr Geneeskd. 2004 Nov 27;148(48):2390-6. Dutch.

PMID:
15615275
26.

Inflammation rather than nutritional depletion determines glutamine concentrations and intestinal permeability.

Hulsewé KW, van der Hulst RW, van Acker BA, von Meyenfeldt MF, Soeters PB.

Clin Nutr. 2004 Oct;23(5):1209-16.

PMID:
15380915
27.

Helicobacter pylori and functional dyspepsia. What to do after the Maastricht II consensus meeting?

Loffeld RJ, van der Hulst RW.

Scand J Gastroenterol Suppl. 2002;(236):19-21. Review.

PMID:
12408499
28.
29.

How do primary care physicians use long-term acid suppressant drugs? A population-based analysis of Dutch general practices.

Hurenkamp GJ, Grundmeyer HG, Bindels PJ, Tytgat GN, Van Der Hulst RW.

J Fam Pract. 2002 Mar;51(3):241-5.

PMID:
11978235
30.

Suppression of Helicobacter pylori infection during intensive care stay: related to stress ulcer bleeding incidence?

van der Voort PH, van der Hulst RW, Zandstra DF, Geraedts AA, van der Ende A, Tytgat GN.

J Crit Care. 2001 Dec;16(4):182-7.

PMID:
11815904
31.

Arrest of chronic acid suppressant drug use after successful Helicobacter pylori eradication in patients with peptic ulcer disease: a six-month follow-up study.

Hurenkamp GJ, Grundmeijer HG, Van Der Ende A, Tytgat GN, Assendelft WJ, Van Der Hulst RW.

Aliment Pharmacol Ther. 2001 Jul;15(7):1047-54.

32.

Comparison of precancerous conditions: atrophy and intestinal metaplasia in Helicobacter pylori gastritis among Chinese and Dutch patients.

Chen XY, van Der Hulst RW, Shi Y, Xiao SD, Tytgat GN, Ten Kate FJ.

J Clin Pathol. 2001 May;54(5):367-70.

33.

Prevalence of Helicobacter pylori infection in stress-induced gastric mucosal injury.

van der Voort PH, van der Hulst RW, Zandstra DF, Geraedts AA, van der Ende A, Tytgat GN.

Intensive Care Med. 2001 Jan;27(1):68-73.

PMID:
11280676
34.

Gut decontamination of critically ill patients reduces Helicobacter pylori acquisition by intensive care nurses.

van der Voort PH, van der Hulst RW, Zandstra DF, van der Ende A, Kesecioglu J, Geraedts AA, Tytgat GN.

J Hosp Infect. 2001 Jan;47(1):41-5.

PMID:
11161897
35.

In vitro susceptibility of Helicobacter pylori to, and in vivo suppression by, antimicrobials used in selective decontamination of the digestive tract.

van der Voort PH, van der Hulst RW, Zandstra DF, van der Ende A, Geraedts AA, Tytgat GN.

J Antimicrob Chemother. 2000 Nov;46(5):803-5.

PMID:
11062202
36.

Equally high efficacy of 4, 7 and 10-day triple therapies to eradicate Helicobacter pylori infection in patients with ulcer disease.

Hurenkamp GJ, Van Der Ende A, Grundmeijer HG, Tytgat GN, Van Der Hulst RW.

Aliment Pharmacol Ther. 2000 Aug;14(8):1065-70.

37.

[Stress ulcer prophylaxis in the intensive care unit].

van der Voort PH, Zandstra DF, van der Hulst RW.

Ned Tijdschr Geneeskd. 2000 Apr 1;144(14):679-80. Dutch. No abstract available.

PMID:
10774297
38.

H pylori colocalises with MUC5AC in the human stomach.

Van den Brink GR, Tytgat KM, Van der Hulst RW, Van der Loos CM, Einerhand AW, Büller HA, Dekker J.

Gut. 2000 May;46(5):601-7.

39.

Interobserver variation in the histopathological scoring of Helicobacter pylori related gastritis.

Chen XY, van der Hulst RW, Bruno MJ, van der Ende A, Xiao SD, Tytgat GN, Ten Kate FJ.

J Clin Pathol. 1999 Aug;52(8):612-5.

40.

Quasispecies development of Helicobacter pylori observed in paired isolates obtained years apart from the same host.

Kuipers EJ, Israel DA, Kusters JG, Gerrits MM, Weel J, van Der Ende A, van Der Hulst RW, Wirth HP, Höök-Nikanne J, Thompson SA, Blaser MJ.

J Infect Dis. 2000 Jan;181(1):273-82.

41.

Evaluation of three commercial serological tests with different methodologies to assess Helicobacter pylori infection.

van Der Ende A, van Der Hulst RW, Roorda P, Tytgat GN, Dankert J.

J Clin Microbiol. 1999 Dec;37(12):4150-2.

42.

Laser assisted ratio analyser 13C-urea breath testing, for the detection of H. pylori: A prospective diagnostic European multicentre study.

Van Der Hulst RW, Lamouliatte H, Megraud F, Pounder RE, Stolte M, Vaira D, Williams M, Tytgat GN.

Aliment Pharmacol Ther. 1999 Sep;13(9):1171-7.

43.

Esophageal lichen planus.

Bobadilla J, van der Hulst RW, ten Kate FJ, Tytgat GN.

Gastrointest Endosc. 1999 Aug;50(2):268-71. Review. No abstract available.

PMID:
10425426
44.

Relation between vacA subtypes, cytotoxin activity, and disease in Helicobacter pylori-infected patients from The Netherlands.

Pan ZJ, van der Hulst RW, Tytgat GN, Dankert J, van der Ende A.

Am J Gastroenterol. 1999 Jun;94(6):1517-21.

PMID:
10364017
45.

[Chronic use of stomach acid inhibitor medication in family practice in the region of Amsterdam].

Hurenkamp GJ, Grundmeijer HG, Bindels PJ, Tytgat GN, van der Hulst RW.

Ned Tijdschr Geneeskd. 1999 Feb 20;143(8):410-3. Dutch.

PMID:
10221111
46.

[Laser-assisted 13C-urea breath test; a new noninvasive detection method for Helicobacter pylori infection].

van der Hulst RW, Hensen EF, van der Ende A, Kruizinga SP, Homan A, Tytgat GN.

Ned Tijdschr Geneeskd. 1999 Feb 20;143(8):400-4. Dutch.

PMID:
10221110
47.

[Treatment of Helicobacter pylori infections].

van der Hulst RW, van 't Hoff BW, van der Ende A, Tytgat GN.

Ned Tijdschr Geneeskd. 1999 Feb 20;143(8):395-400. Review. Dutch.

PMID:
10221109
48.

[Pathophysiology of Helicobacter pylori infections].

van der Ende A, van der Hulst RW, Tytgat GN, Dankert J.

Ned Tijdschr Geneeskd. 1999 Feb 20;143(8):392-5. Review. Dutch.

PMID:
10221108
49.

Prevalence of vacuolating cytotoxin production and distribution of distinct vacA alleles in Helicobacter pylori from China.

Pan ZJ, Berg DE, van der Hulst RW, Su WW, Raudonikiene A, Xiao SD, Dankert J, Tytgat GN, van der Ende A.

J Infect Dis. 1998 Jul;178(1):220-6.

PMID:
9652444
50.

cagA-positive Helicobacter pylori populations in China and The Netherlands are distinct.

van der Ende A, Pan ZJ, Bart A, van der Hulst RW, Feller M, Xiao SD, Tytgat GN, Dankert J.

Infect Immun. 1998 May;66(5):1822-6. Erratum in: Infect Immun 2000 Jan;68(1):427.

Supplemental Content

Loading ...
Support Center